Use of antidepressants near delivery and risk of postpartum hemorrhage: Cohort study of low income women in the United States

BMJ (Online)

Volumn 347, Issue 7922, 2013, Pages

  Palmsten, Kristin ^a   Hernández Díaz, Sonia ^a   Huybrechts, Krista F ^b   Williams, Paige L ^a   Michels, Karin B ^a,b,c   Achtyes, Eric D ^d   Mogun, Helen ^b   Setoguchi, Soko ^a,e  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

^d MICHIGAN STATE UNIVERSITY   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EXPOSURE; DRUG USE; FEMALE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; POSTPARTUM HEMORRHAGE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; CHILD; CONFOUNDING FACTORS (EPIDEMIOLOGY); DELIVERY, OBSTETRIC; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; MEDICAID; MIDDLE AGED; MOOD DISORDERS; OBESITY; OUTCOME ASSESSMENT (HEALTH CARE); POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, THIRD; SEROTONIN UPTAKE INHIBITORS; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84883254579     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f4877     Document Type: Article

References (60)

1. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010;116:1302-9.
2. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 2006;108:1039-47.
3. Baskett TF, O'Connell CM. Severe obstetric maternal morbidity: a 15-year population-based study. J Obstet Gynaecol 2005;25:7-9. (Pubitemid 41685665)
4. Gilbert TT, Smulian JC, Martin AA, Ananth CV, Scorza W, Scardella AT. Obstetric admissions to the intensive care unit: outcomes and severity of illness. Obstet Gynecol 2003;102:897-903. (Pubitemid 37412275)
5. Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010;202:353.
6. Joseph KS, Rouleau J, Kramer MS, Young DC, Liston RM, Baskett TF. Investigation of an increase in postpartum haemorrhage in Canada. BJOG 2007;114:751-9. (Pubitemid 46788638)
7. Ford JB, Roberts CL, Simpson JM, Vaughan J, Cameron CA. Increased postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet 2007;98:237-43. (Pubitemid 47210992)
8. Knight M, Callaghan WM, Berg C, Alexander S, Bouvier-Colle MH, Ford JB, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 2009;9:55.
9. Van Walraven C, Mamdani MM, Wells PS, Williams JI. Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study. BMJ 2001;323:655-8. (Pubitemid 32897004)
10. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med 2004;164:2367-70. (Pubitemid 39532249)
11. De Abajo FJ. Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients. Drugs Aging 2011;28:345-67.
12. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 2011;343:d4551.
13. Castro VM, Gallagher PJ, Clements CC, Murphy SN, Gainer VS, Fava M, et al. Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressants. BMJ Open 2012;2:e000544.
14. Lee YC, Shau WY, Chang CH, Chen ST, Lin MS, Lai MS. Antidepressant use and the risk of upper gastrointestinal bleeding in psychiatric patients: a nationwide cohort study in Taiwan. J Clin Psychopharmacol 2012;32:518-24.
15. De Abajo FJ, Rodriguez LA, Montero D. Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 1999;319:1106-9. (Pubitemid 29494721)
16. Cooper WO, Willy ME, Pont SJ, Ray WA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007;196:544.
17. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol 2008;198:194.
18. Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernandez-Diaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 2011;205:51.
19. Salkeld E, Ferris LE, Juurlink DN. The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 2008;28:230-4. (Pubitemid 351417131)
20. Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010;40:1723-33.
21. Palmsten K, Huybrechts KF, Mogun H, Setoguchi S, Hernández- Díaz S. Harnessing the Medicaid Analytic eXtract (MAX) to evaluate medications in pregnancy: design considerations. PLoS ONE 2013;8:e67405. www.plosone.org/article/info%3Adoi%2F10. 1371%2Fjournal.pone.0067405
22. Hubrechts KF, Palmsten K, Mogun H, Kowal M, Avorn J, Setoguchi-Iwata S, et al. National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry 2013;35:265-71.
23. Palmsten K, Huybrechts KF, Michels KB, Williams PL, Mogun H, Setoguchi S, et al. Antidepressant use and risk for preeclampsia. Epidemiology . 2013;24:682-91.
24. West SL, Richter A, Melfi CA, McNutt M, Nennstiel ME, Mauskopf JA. Assessing the Saskatchewan database for outcomes research studies of depression and its treatment. J Clin Epidemiol 2000;53:823-31. (Pubitemid 30609647)
25. Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin Obstet Gynecol 2010;53:147-156.
26. O'Donnell JM, Shelton RC. Drug therapy of depression and anxiety disorders. In: Brunton LL, Chabner BA, Knollmann BC, eds. Goodman & Gilman's the pharmacological basis of therapeutics. 12th ed. McGraw-Hill, 2011.
27. Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 1997;340:249-58. (Pubitemid 28022649)
28. Owens MJ, Knight DL, Nemeroff CB. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 2001;50:345-50. (Pubitemid 32816947)
29. Kuo F, Gillespie TA, Kulanthaivel P, Lantz RJ, Ma TW, Nelson DL, et al. Synthesis and biological activity of some known and putative duloxetine metabolites. Bioorg Med Chem Lett 2004;14:3481-6. (Pubitemid 38737151)
30. Magann EF, Evans S, Hutchinson M, Collins R, Howard BC, Morrison JC. Postpartum hemorrhage after vaginal birth: an analysis of risk factors. South Med J 2005;98:419-22. (Pubitemid 40530326)
31. Kramer MS, Dahhou M, Vallerand D, Liston R, Joseph KS. Risk factors for postpartum hemorrhage: can we explain the recent temporal increase? J Obstet Gynaecol Can 2011;33:810-9.
32. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 2001;154:854-64. (Pubitemid 33000813)
33. Hernan MA, Hernandez-Diaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002;155:176-84. (Pubitemid 34072741)
34. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005;162:199-200. (Pubitemid 41373523)
35. Zou GY, Donner A. Extension of the modified Poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res 2011 Nov 8, Epub ahead of print.
36. Rassen JA, Glynn RJ, Brookhart MA, Schneeweiss S. Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol 2011;173:1404-13.
37. Rassen JA, Doherty M, Huang W, Schneeweiss S. Pharmacoepidemiology toolbox. www.hdpharmacoepi.org.
38. Ananth CV, VanderWeele TJ. Placental abruption and perinatal mortality with preterm delivery as a mediator: disentangling direct and indirect effects. Am J Epidemiol 2011;174:99-108.
39. Valeri L, VanderWeele TJ. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods 2013;18:137-50.
40. Walker AM. Observation and inference. Epidemiology Resources, 1991.
41. Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Safety 2006;15:291-303. (Pubitemid 43797117)
42. National Health and Nutrition Examination Survey (NHANES). Analytic and reporting guidelines.National Center for Health Statistics, Centers for Disease Control and Prevention. 2005. www.cdc.gov/nchs/data/nhanes/nhanes-03-04/nhanes- analytic-guidelines-dec-2005.pdf.
43. Blomberg M. Maternal obesity and risk of postpartum hemorrhage. Obstet Gynecol 2011;118:561-8.
44. Fyfe EM, Thompson JM, Anderson NH, Groom KM, McCowan LM. Maternal obesity and postpartum haemorrhage after vaginal and caesarean delivery among nulliparous women at term: a retrospective cohort study. BMC Pregnancy Childbirth 2012;12:112.
45. Thase ME. Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 1998;59:502-8. (Pubitemid 28492413)
46. Thase ME, Tran PV, Wiltse C, Pangallo BA, Mallinckrodt C, Detke MJ. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. J Clin Psychopharmacol 2005;25:132-40. (Pubitemid 40395091)
47. Hernan MA, Hernandez-Diaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004;15:615-25. (Pubitemid 40416916)
48. Andersen J, Kristensen AS, Bang-Andersen B, Stromgaard K. Recent advances in the understanding of the interaction of antidepressant drugs with serotonin and norepinephrine transporters. Chem Commun (Camb) 2009;25:3677-92.
49. Cordeaux Y, Pasupathy D, Bacon J, Charnock-Jones DS, Smith GC. Characterization of serotonin receptors in pregnant human myometrium. J Pharmacol Exp Ther 2009;328:682-91.
50. de Abajo FJ, Montero D, Rodriguez LA, Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol 2006;98:304-10.
51. Clark SM, Nakad R. Pharmacotherapeutic management of nicotine dependence in pregnancy. Obstet Gynecol Clin North Am 2011;38:297-311.
52. Guirgis RR, Clark AD, Hogston P, Golland IM, Bevan JR, Francis JG, et al. The effects of smoking on labour after uncomplicated pregnancy: a comparison between the progress and outcome of labour in 400 smokers and 400 matched non-smokers. J Obstet Gynaecol 1997;17:149-52. (Pubitemid 27187277)
53. Marchant S, Alexander J, Thomas P, Garcia J, Brocklehurst P, Keene J. Risk factors for hospital admission related to excessive and/or prolonged postpartum vaginal blood loss after the first 24 h following childbirth. Paediatr Perinat Epidemiol 2006;20:392-402.
54. Stewart D. Clinical practice. Depression during pregnancy. N Engl J Med 2011;365:1605-11.
55. Nonacs R, Cohen LS. Assessment and treatment of depression during pregnancy: an update. Psychiatr Clin North Am 2003;26:547-62. (Pubitemid 37175495)
56. Werler AA, Hernandez-Diaz S, Honein MA. Over-the-counter medications during pregnancy. Am J Obstet Gynecol 2005;193:771-7.
57. Stephansson O, Granath F, Svensson T, Haglund B, Ekbom A, Kieler H. Drug use during pregnancy in Sweden - assessed by the Prescribed Drug Register and the Medical Birth Register. Clin Epidemiol 2011;3:43-50.
58. Romano PS, Yasmeen S, Schembri ME, Keyzer JM, Gilbert WM. Coding of perineal lacerations and other complications of obstetric care in hospital discharge data. Obstet Gynecol 2005;106:717-25. (Pubitemid 41362174)
59. Garcia G. Maternal and Child Health (MCH) Update: States Increase Eligibility for Children's Health in 2007. www.nga.org/files/live/sites/NGA/ files/pdf/0811MCHUPDATE. PDF;jsessionid=7B47A647247DD4E5CB9B709C8F9797AE.
60. Martin JA, Hamilton BE, Ventura SJ, Osterman MJ. Wilson EC, Mathews TJ. Births: final data for 2011. Natl Vital Stat Rep 2012;61:1-71.